Association of pancreatitis with administration of contrast medium and intravenous lipid emulsion in a patient with the acquired immunodeficiency syndrome

Southern Medical Journal

Volumn 96, Issue 1, 2003, Pages 66-69

  Kasi, Vijaykumar S ^a,c   Estrada, Carlos A ^a   Wiese, Wilhelmine ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PITT COUNTY MEMORIAL HOSPITAL   (United States)

Author keywords

Acquired immunodeficiency syndrome; Contrast medium; Hypertriglyceridemia; Intravenous lipid emulsion; Lipase; Lipids; Pancreatitis; Total parenteral nutrition

Indexed keywords

ABACAVIR; AMINE; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CILASTATIN; CIPROFLOXACIN; CONTRAST MEDIUM; COTRIMOXAZOLE; DIATRIZOATE; DIDANOSINE; ETHAMBUTOL; FAMOTIDINE; IMIPENEM; INTRALIPID; IOHEXOL; LIPID EMULSION; PREDNISONE; PROCALAMINE; STAVUDINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VALACICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ARTICLE; BACTEREMIA; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; FEMALE; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MYCOBACTERIUM AVIUM; NOCARDIA FARCINICA; PANCREATITIS; PATIENT MONITORING; PNEUMONIA; PSEUDOMONAS AERUGINOSA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACUTE DISEASE; ADULT; CONTRAST MEDIA; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; IOHEXOL; PANCREATITIS;

EID: 0037274853     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000047667.00302.CD     Document Type: Article

References (17)

1. Ranson JHC. Etiological and prognostic factors in human pancreatitis: A review. Am J Gastroenterol 1982;77:633-638.
2. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
3. Fauci AS, Macher AM, Longo DL. NIH conferences on AIDS: Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100:92-106.
4. Schwartz MS, Brandt LJ. The spectrum of pancreatic disorders in patients with the acquired immunodeficiency syndrome. Am J Gastroenterol 1989;84:459-462.
5. Foitzik T, Bassi DG, Schmidt J, et al. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology, 1994;106:207-214.
6. McMenamin DA, Gates LK. A retrospective analysis of the effect of contrast enhanced CT on the outcome of acute pancreatitis. Am J Gastroenterol 1996;91:1384-1387.
7. Carmona-Sanchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg 2000;135:1280-1284.
8. Marulendra S, Kirby DF. Nutrition support in acute pancreatitis. Nutr Clin Pract 1995;10:45-53.
9. Tashiro T. Intralipid and essential fatty acid deficiency in infants. J Pediatr Surg 1976;11:505-515.
10. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipemia: The incidence of lipid abnormalities in acute pancreatitis. Ann Surg 1973;177:483-489.
11. Leibowitz AB, O'Sullivan P, Iberti TJ: Intravenous fat emulsions and the pancreas: A review. Mt Sinai J Med 1992;59:38-42.
12. Noseworthy J, Colodny AH, Eraklis AJ. Pancreatitis and intravenous fat: An association in patients with inflammatory bowel disease. J Pediatr Surg 1983;18:269-272.
13. Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease. Gastroenterology 1986;90:1039-1041.
14. Buckspan R, Woltering E, Waterhouse G. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient. South Med J 1984;77:251-252.
15. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-590.
16. Edelman K, Valenzuela JE. Effect of intravenous lipid on human pancreatic secretion. Gastroenterology 1983;85:1063-1066.
17. Saharia P, Margolis S, Zuidema GD, Cameron JL. Acute pancreatitis with hyperlipidemia: Studies with an isolated perfused canine pancreas. Surgery 1977;82:60-67.